Medikit Co.,Ltd.
Research Medikit Co.,Ltd. (7749.T) on Bullrun: market cap JPY 39.37B, P/E 12.7, dividend yield 3.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7749.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyJPY
- Market capJPY 39.37B
- P/E12.7
- Dividend yield3.8%
- Financial periodFY2026
- RevenueJPY 23.78B
- Revenue growth5.4%
- Net incomeJPY 3.01B
- Free cash flowJPY 1.25B
- Gross margin37.9%
Valuation Snapshot
latest market cap is JPY 39.37B; P/E is 12.7; dividend yield is 3.8%.
Peer valuation comparison
Latest P/E is 12.65x versus a Healthcare sector median of 21.69x (41.7% below).
Latest dividend yield is 3.75% versus a Healthcare sector median of 2.41% (55.6% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 23.78B | JPY 3.01B | JPY 1.25B | 37.9% | 206.37 | JPY 20.95B | JPY 18.97M | JPY 46.78B |
| FY2025 | JPY 22.55B | JPY 3.01B | -JPY 288.06M | 38.4% | 204.55 | JPY 21.56B | JPY 0 | JPY 45.16B |
| FY2024 | JPY 21.85B | JPY 3.07B | JPY 3.13B | 40.1% | 187.95 | JPY 23.61B | n/a | JPY 44.13B |
| FY2023 | JPY 21.61B | JPY 2.86B | JPY 3.45B | 38.5% | 170.67 | JPY 27.59B | n/a | JPY 47.29B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 39.37B | 12.7 | 3.7% | 100 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 100 JPY, yield 3.8%.
| Year | Dividends/share |
|---|---|
| FY2026 | 100 JPY |
| FY2025 | 95 JPY |
| FY2024 | 90 JPY |
| FY2023 | 105 JPY |
| FY2022 | 90 JPY |
About Medikit Co.,Ltd.
Medikit Co.,Ltd., together with its subsidiaries, develops, manufactures, and sells medical devices related to blood vessels and blood in Japan and internationally. The company offers IV catheters, such as Supercath 5 and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath sheath introducers and Mongoose angiography catheters. It also provides indwelling needles for artificial dialysis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Medikit Co.,Ltd.'s market cap?
Medikit Co.,Ltd.'s market capitalization is JPY 39.37B.
What is Medikit Co.,Ltd.'s P/E ratio?
Medikit Co.,Ltd.'s price-to-earnings (P/E) ratio is 12.7.
Does Medikit Co.,Ltd. pay a dividend?
Medikit Co.,Ltd. has a dividend yield of 3.8%.
What does Medikit Co.,Ltd. do?
Medikit Co.,Ltd., together with its subsidiaries, develops, manufactures, and sells medical devices related to blood vessels and blood in Japan and internationally. The company offers IV catheters, such as Supercath 5 and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath sheath introducers and Mongoose angiography catheters. It also provides indwelling needles for artificial dialysis; and needles for blood transfusions and intravenous fluid. Medikit Co.,Ltd.